HLNE Stock Analysis: Hamilton Lane | NASDAQ

Private Equity, Venture Capital, Direct Credit, Fund Investments

Total Rating 51

Safety 70

Buy Signal -0.42

Asset Management
Industry Rotation: -5.1

Market Cap: 5.83B
Avg Turnover: 56.8M

Risk 3d forecast

Volatility32.3%

VaR 5^th Pctl5.80%

VaR vs Median9.06%

Reward TTM

Sharpe Ratio-0.65

Rel. Str. IBD18.2

Rel. Str. Peer Group20.7

Character TTM

Beta1.405

Beta Downside1.463

Hurst Exponent0.497

Drawdowns 3y

Max DD62.26%

CAGR/Max DD0.02

CAGR/Mean DD0.05

EPS (Earnings per Share)

EPS CAGR: 24.85%
EPS Trend: 95.4%

Last SUE: 2.54
Qual. Beats: 1

Revenue

Rev. CAGR: 12.72%
Rev. Trend: 92.6%

Last SUE: 2.83
Qual. Beats: 1

Warnings

Below Avwap Earnings

Below Sma 200d

Tailwinds

Confidence

Seasonality 9.6 years of data

Jan +1.1% 18

Feb -7.2% 26

Mar -3.7% 57

Apr -0.2% 13

May +1.6% 6

Jun -1.7% 25

Jul +3.8% 47

Aug -1.0% 5

Sep -9.6% 56

Oct +1.5% 15

Nov +0.4% 5

Dec -1.0% 2

How good or bad each month usually is (without trend). The score below shows how much you can trust it: 0 = pure chance, >40 gets interesting and >55 is strong.

Description: HLNE Hamilton Lane

Hamilton Lane Incorporated (NASDAQ: HLNE) is a Philadelphia-based private markets investment firm founded in 1991 that provides clients with access to private equity, venture capital, credit, and real assets through a range of structures, including direct investments, primary and secondary fund of funds, evergreen vehicles, and customized solutions. The firm invests across the full private equity life cycle, from early venture and growth equity to buyouts, distressed, and mezzanine financings, generally committing between $0.25 million and $100 million per transaction and typically taking majority stakes in small- to mid-sized companies.

Its geographic and sector reach is broad, spanning North America, Europe, Asia/Pacific, the Middle East, Africa, and Latin America, with portfolio exposure concentrated in technology, healthcare, financials, consumer, industrials, energy, and tech-enabled businesses. Listed on NASDAQ since March 2017, Hamilton Lane is classified within the GICS Asset Management & Custody Banks sub-industry and operates additional offices across Europe, North America, Asia Pacific, and the Middle East.

Headlines to Watch Out For

Private market AUM growth drives fee-related earnings higher
Alternative fundraising competition intensifies from Blackstone and KKR
Capital allocation through dividends and share buybacks continues

Piotroski VR-10 (Strict) 5.5

Net Income: 275.9m TTM > 0 and > 6% of Revenue
FCF/TA: 0.15 > 0.02 and ΔFCF/TA -3.29 > 1.0
NWC/Revenue: 51.24% < 20% (prev 27.81%; Δ 23.43% < -1%)
CFO/TA 0.16 > 3% & CFO 399.0m > Net Income 275.9m
Net Debt (118.4m) to EBITDA (541.9m): 0.22 < 3
Current Ratio: 4.05 > 1.5 & < 3
Outstanding Shares: last quarter (54.4m) vs 12m ago -0.10% < -2%
Gross Margin: 69.89% > 18% (prev 71.00%; Δ -1.11% > 0.5%)
Asset Turnover: 39.55% > 50% (prev 38.41%; Δ 1.14% > 0%)
Interest Coverage Ratio: 36.46 > 6 (EBIT TTM 532.0m / Interest Expense TTM 14.6m)

Altman Z'' 4.81

A: 0.17 (Total Current Assets 584.1m - Total Current Liabilities 144.3m) / Total Assets 2.54b
B: 0.26 (Retained Earnings 670.5m / Total Assets 2.54b)
C: 0.25 (EBIT TTM 532.0m / Avg Total Assets 2.17b)
D: 1.11 (Book Value of Equity 939.3m / Total Liabilities 846.6m)
Altman-Z'' = 4.81 = AA

Beneish M -2.76

DSRI: 1.03 (Receivables 228.0m/178.2m, Revenue 858.4m/692.2m)
GMI: 1.02 (GM 71.00% / 69.89%)
AQI: 1.10 (AQ_t 0.73 / AQ_t-1 0.66)
SGI: 1.24 (Revenue 858.4m / 692.2m)
TATA: -0.05 (NI 275.9m - CFO 399.0m) / TA 2.54b)
Beneish M = -2.76 (Cap -4..+1) = A

What is the price of HLNE shares?

As of October 09, 2026, the stock is trading at USD 85.66 with a total of 642,776 shares traded. Over the past week, the price has changed by -3.29%, over one month by -14.75%, over three months by +9.23% and over the past year by -26.79%.

Current recommended Stop Loss: 80.70 (which is 5.8% or 1.4 ATR below the current price).

Is HLNE a buy, sell or hold?

Hamilton Lane has received a consensus analysts rating of 4.50. Therefore, it is recommended to buy HLNE.

StrongBuy: 5
Buy: 2
Hold: 1
Sell: 0
StrongSell: 0

What are the forecasts/targets for the HLNE price?

Analysts Target Price	129.4	51%

Hamilton Lane (HLNE) - Fundamental Data Overview as of 06 October 2026

Market Cap USD = 5.83b (5.83b USD * 1.0 USD.USD)
P/E Trailing = 13.2481
P/E Forward = 12.0192
P/S = 6.7962
P/B = 5.0351
P/EG = 1.39
Revenue TTM = 858.4m USD
EBIT TTM = 532.0m USD
EBITDA TTM = 541.9m USD
Long Term Debt = 274.2m USD (from longTermDebt, last quarter)
Short Term Debt = unknown (none)
Debt = 455.4m USD (from shortLongTermDebtTotal, last quarter) + Leases 90.6m
Net Debt = 118.4m USD (calculated: Debt 455.4m - CCE 337.0m)
Enterprise Value = 5.95b USD (5.83b + Debt 455.4m - CCE 337.0m)
Interest Coverage Ratio = 36.46 (Ebit TTM 532.0m / Interest Expense TTM 14.6m)
EV/FCF = 15.16x (Enterprise Value 5.95b / FCF TTM 392.7m)
FCF Yield = 6.60% (FCF TTM 392.7m / Enterprise Value 5.95b)
FCF Margin = 45.75% (FCF TTM 392.7m / Revenue TTM 858.4m)
Net Margin = 32.14% (Net Income TTM 275.9m / Revenue TTM 858.4m)
Gross Margin = 69.89% ((Revenue TTM 858.4m - Cost of Revenue TTM 258.4m) / Revenue TTM)
Gross Margin QoQ = 69.74% (prev 69.78%)
Tobins Q-Ratio = 2.34 (Enterprise Value 5.95b / Total Assets 2.54b)
Interest Expense / Debt = 3.20% (Interest Expense 14.6m / Debt 455.4m)
Taxrate = 15.83% (81.9m / 517.4m)
NOPAT = 447.8m (EBIT 532.0m * (1 - 15.83%))
Current Ratio = 4.05 (Total Current Assets 584.1m / Total Current Liabilities 144.3m)
Debt / Equity = 0.48 (Debt 455.4m / totalStockholderEquity, last quarter 939.3m)
Debt / EBITDA = 0.22 (Net Debt 118.4m / EBITDA 541.9m)
Debt / FCF = 0.30 (Net Debt 118.4m / FCF TTM 392.7m)
Total Stockholder Equity = 889.4m (last 4 quarters mean from totalStockholderEquity)
RoA = 12.71% (Net Income 275.9m / Total Assets 2.54b)
RoE = 31.02% (Net Income TTM 275.9m / Total Stockholder Equity 889.4m)
RoCE = 45.72% (EBIT 532.0m / Capital Employed (Equity 889.4m + L.T.Debt 274.2m))
RoIC = 19.04% (NOPAT 447.8m / Invested Capital 2.35b)
WACC = 10.33% (E(5.83b)/V(6.29b) * Re(10.93%) + D(455.4m)/V(6.29b) * Rd(3.20%) * (1-Tc(0.16)))
Discount Rate = 10.93% (= CAPM, Blume Beta Adj.)
Shares (quarterly) Correlation: 7.55 | Cagr: -0.03%
[DCF] Terminal Value 71.83% ; FCFF base≈370.8m ; Y1≈425.1m ; Y5≈625.6m
[DCF] Fair Price = 158.1 (EV 6.97b - Net Debt 118.4m = Equity 6.85b / Shares 43.3m; r=10.33% [WACC]; 5y FCF grow 15.0% → 2.50% )
EPS Correlation: 95.38 | EPS CAGR: 24.85% | SUE: 2.54 | # QB: 1
Revenue Correlation: 92.58 | Revenue CAGR: 12.72% | SUE: 2.83 | # QB: 1
EPS current Quarter (2026-09-30): EPS=1.71 | Chg30d=-0.63% | Revisions=+57% | Analysts=6
EPS next Quarter (2026-12-31): EPS=1.67 | Chg30d=+1.56% | Revisions=+57% | Analysts=6
EPS current Year (2027-03-31): EPS=7.43 | Chg30d=-0.44% | Revisions=+57% | GrowthEPS=+26.0% | GrowthRev=+27.5%
EPS next Year (2028-03-31): EPS=7.34 | Chg30d=-0.53% | Revisions=+12% | GrowthEPS=-1.3% | GrowthRev=+8.3%
[Analyst] Revisions Ratio: +65% (up=15, down=2)